epirubicin has been researched along with Anemia, Fanconi in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keck, JL; Manthei, KA; Voter, AF | 1 |
| Boyle, D; Bylesjo, M; Couch, FJ; Davison, TS; Deharo, S; Hill, LA; Irwin, G; James, CR; James, J; Johnston, PG; Keating, KE; Kennedy, RD; Kerr, P; Lindor, NM; McDyer, FA; Mullan, PB; Mulligan, JM; O'Brien, E; Paul Harkin, D; Proutski, V; Quinn, JE; Raji, OY; Salto-Tellez, M; Walker, SM | 1 |
2 other study(ies) available for epirubicin and Anemia, Fanconi
| Article | Year |
|---|---|
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases | 2016 |
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; DNA Damage; DNA, Neoplasm; Epirubicin; Fanconi Anemia; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Oligonucleotide Array Sequence Analysis; Prospective Studies | 2014 |